Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
Comparison of Investigator-Reported vs Centrally Adjudicated Major Adverse Cardiac Events
Prakriti Gaba, Deepak L. Bhatt, Gilles R. Dagenais, Jackie Bosch, Aldo Maggioni, Petr Widimský, Darryl P. Leong, Keith A.A. Fox, Salim Yusuf, John W. Eikelboom, Salim Yusuf, Keith A.A. Fox, John W. Eikelboom, Jackie Bosch, Victor Aboyans, Marco Alings, Sonia S. Anand, Álvaro Avezum, Deepak L. Bhatt, Kelley R. Branch, Patrick Commerford, Nancy Cook‐Bruns, Gilles R. Dagenais, Antonio L. Dans, Rafael Díaz, Georg Ertl, Camilo Félix, Tomasz J. Guzik, Robert G. Hart, Masatsugu Hori, Ajay K. Kakkar, Katalin Keltai, Matyàs Keltai, Jae‐Hyung Kim, André Lamy, Fernando Laņas, Basil S. Lewis, Yan Liang, Lisheng Liu, Eva Lonn, Patricio López‐Jaramillo, Aldo Maggioni, Kaj Metsärinne, Paul Moayyedi, Martin O’Donnell, Alexander Parkhomenko, Leopoldo Soares Piegas, Nana Pogosova, Jeffrey L. Probstfield, Lars Rydén, Mukul Sharma, Philippe Gabríel Steg, Stefan Störk, Andrew M. Tonkin, Christian Torp‐Pedersen, George Varigos, Peter Verhamme, Dragoş Vinereanu, Petr Widimský, K. Yusoff, Jun Zhu (2022). Comparison of Investigator-Reported vs Centrally Adjudicated Major Adverse Cardiac Events. , 5(11), DOI: https://doi.org/10.1001/jamanetworkopen.2022.43201.
Article7 days agoBaseline characteristics of patients with atrial fibrillation and cancer enrolled in the BLITZ-AF Cancer registry
Pietro Ameri, Marco Alings, Furio Colivicchi, Rónán Collins, Livio De Luca, Marcello Di Nisio, Gianna Fabbri, Domenico Gabrielli, S.P. Janssens, Aldo Maggioni, I Parrini, Fausto J. Pinto, Fabio Maria Turazza, J. L. Zamorano, Michele Massimo Gulizia (2022). Baseline characteristics of patients with atrial fibrillation and cancer enrolled in the BLITZ-AF Cancer registry. , 43(Supplement_2), DOI: https://doi.org/10.1093/eurheartj/ehac544.525.
Article7 days agoC67A BLITZ-AF CANCER REGISTRY: BASELINE CHARACTERISTICS OF PATIENTS WITH ATRIAL FIBRILLATION AND CANCER
Michele Massimo Gulizia, Pietro Ameri, Marco Alings, Rónán Collins, Leonardo De Luca, Marcello Di Nisio, Gianna Fabbri, Domenico Gabrielli, Stefan Janssens, Aldo Maggioni, Iris Parrini, Fausto J. Pinto, Fabio Maria Turazza, José Luis Zamorano, Furio Colivicchi (2022). C67A BLITZ-AF CANCER REGISTRY: BASELINE CHARACTERISTICS OF PATIENTS WITH ATRIAL FIBRILLATION AND CANCER. , 24(Supplement_C), DOI: https://doi.org/10.1093/eurheartj/suac011.065a.
Article7 days agoLong-Term Treatment with the Combination of Rivaroxaban and Aspirin in Patients with Chronic Coronary or Peripheral Artery Disease: Outcomes During the Open Label Extension of the COMPASS trial
John W. Eikelboom, Jackie Bosch, Stuart J. Connolly, Jessica Tyrwitt, Keith A.A. Fox, Eva Muehlhofer, Christoph Neumann, Christoph Tasto, Shrikant I. Bangdiwala, Rafael Díaz, Marco Alings, Gilles R. Dagenais, Darryl P. Leong, Eva Lonn, Álvaro Avezum, Leopoldo Soares Piegas, Petr Widimský, Alexander Parkhomenko, Deepak L. Bhatt, Kelley R. Branch, Jeffrey L. Probstfield, Patricio López‐Jaramillo, Lars Rydén, Nana Pogosova, Katalin Keltai, Matyàs Keltai, Georg Ertl, Stefan Störk, Antonio L Dans, Fernando Laņas, Yan Liang, Jun Zhu, Christian Torp‐Pedersen, Aldo Maggioni, Patrick Commerford, Tomasz J. Guzik, Thomas Vanassche, Peter Verhamme, Martin O’Donnell, Andrew M. Tonkin, George Varigos, Dragoş Vinereanu, Camillo Felix, Jae‐Hyung Kim, Khairul Shafiq Ibrahim, Basil S. Lewis, Kaj Metsärinne, Victor Aboyans, Philippe Gabríel Steg, Masatsugu Hori, Ajay K. Kakkar, Sonia S. Anand, André Lamy, Mukul Sharma, Salim Yusuf (2022). Long-Term Treatment with the Combination of Rivaroxaban and Aspirin in Patients with Chronic Coronary or Peripheral Artery Disease: Outcomes During the Open Label Extension of the COMPASS trial. , 8(8), DOI: https://doi.org/10.1093/ehjcvp/pvac023.
Article7 days agoLow-dose rivaroxaban plus aspirin in patients with polypharmacy and multimorbidity: an analysis from the COMPASS trial
Thomas Vanassche, Peter Verhamme, Sonia S. Anand, Olga Shestakovska, Darryl P. Leong, Keith A.A. Fox, Deepak L. Bhatt, Álvaro Avezum, Marco Alings, Victor Aboyans, Aldo Maggioni, Petr Widimský, Eva Muehlhofer, Scott D. Berkowitz, Salim Yusuf, Stuart J. Connolly, John W. Eikelboom, Jackie Bosch (2021). Low-dose rivaroxaban plus aspirin in patients with polypharmacy and multimorbidity: an analysis from the COMPASS trial. , 8(5), DOI: https://doi.org/10.1093/ehjcvp/pvab050.
Article7 days ago